Effects of formoterol on histamine induced plasma exudation in induced sputum from normal subjects

Thorax

Volumn 53, Issue 12, 1998, Pages 1010-1013

  Greiff, Lennart ^a   Wollmer, Per ^a   Andersson, Morgan ^a   Svensson, Christer ^a   Persson, Carl G A ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Induced sputum; Plasma exudation; 2 agonists

Indexed keywords

ALPHA 2 MACROGLOBULIN; FORMOTEROL; HISTAMINE; SODIUM CHLORIDE;

ADULT; AIRWAY; ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; EXUDATE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; SPUTUM; SPUTUM ANALYSIS;

EID: 0031701119     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.12.1010     Document Type: Article

References (15)

1. Persson CGA, Erjefält JS, Greiff L, et al. Plasma-derived proteins in airway defence, disease and repair of epithelial injury. Eur Respir J 1998;11:958-70.
2. Persson CGA, Erjefält I, Grega GJ, et al. The role of β-receptor agonists in the inhibition of pulmonary edema. Ann NY Acad Sci 1982;384:544-57.
3. Persson CGA, Erjefält I, Andersson P. Leakage of macromolecules from guinea-pig tracheobronchial microcirculation: effects of allergen, leukotrienes, tachykinins and anti-asthma drugs. Acta Physiol Scand 1986;127: 95-105.
4. Tokuyama K, Lötvall JO, Löfdahl C-G, et al. Inhaled formoterol inhibits histamine-induced airflow obstruction and airway microvascular leakage. Eur J Pharmacol 1991;193:35-9.
5. Advenier C, Quian Y, Law Koune J-D, et al. Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig. Br J Pharmacol 1992;105:792-8.
6. 2-agonists of histamine-induced airway microvascular leakage in ozone-exposed guinea pigs. Am J Respir Crit Care Med 1997;156:723-7.
7. O'Donnell SR, Anderson GP. The effects of formoterol on plasma exudation produced by a localized acute inflammatory response to bradykinin in the tracheal mucosa of rats in vivo. Br J Pharmacol 1995;116:1571-6.
8. 2-adrenergic receptor agonist formoterol reduces microvascular leakage by inhibiting endothelial gap formation. Am J Physiol 1994;266: L461-8.
9. Erjefält I, Persson CGA. Pharmacological control of plasma exudation into tracheobronchial airways. Am Rev Respir Dis 1991;143:1008-14.
10. Erjefält I, Persson CGA. Long duration and high potency of anti-exudative effects of formoterol in guinea-pig tracheobronchial airways. Am Rev Respir Dis 1991;144:788-91.
11. Svensson C, Greiff L, Andersson M, et al. Anti-allergic actions of high topical doses of terbutaline in human nasal airways. Allergy 1995;50:884-90.
12. Birchall MA, O'Connell F, Henderson J, et al. Topical salmeterol reduces protein content of nasal lavage fluid in response to allergen and histamine challenge: double-blind crossover placebo-controlled studies in adults. Am J Rhinol 1996;10:251-6.
13. 2-macroglobulin. Thorax 1997;52:964-8.
14. Pauwels RA, Löfdahl C-G, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997;337:1405-11.
15. 2-macroglobulin into human nasal airways. Clin Exp Allergy 1997;27:438-44.